event,time
39 years old , 0\
female , 0\
palpable mass on her right breast , 0\
Hodgkin lymphoma , -192 months\
chemotherapy , -192 months\
mantle field radiation , -192 months\
inflammatory colitis , -216 months\
mesalazine , -12 months\
invasive ductal carcinoma , 0\
triple-negative phenotype , 0\
MIB1 85% , 0\
neoadjuvant chemotherapy , 0\
paclitaxel , 0\
carboplatin , 0\
port-Ã -cath insertion , 48\
fever , 72\
subcutaneous cellulitis , 72\
colliquative necrosis , 72\
elevated white blood cell count , 72\
neutrophilia , 72\
elevated C-reactive protein , 72\
broad-spectrum i.v. antibiotic therapy , 72\
piperacillin/tazobactam , 72\
daptomycin , 72\
PORT rimotion , 72\
necrosectomy , 72\
defervescence , 96\
improvement in subcutaneous cellulitis , 96\
improvement in blood works , 96\
febrile seizure , 120\
WBC rise , 120\
worsening of skin lesion , 120\
second necrosectomy , 120\
peripheral blood cultures negative , 120\
skin plug negative , 120\
i.v. catheter tip positivity for Klebsiella pneumoniae , 120\
meropenem , 120\
levofloxacin , 120\
mediastinitis , 120\
bilateral pleural effusion , 120\
left pulmonary atelectasis , 120\
thoracoscopy , 120\
pleural and mediastinal drainage , 120\
sepsis , 120\
broad-spectrum antibiotic and antifungal therapy , 120\
hemodynamic support , 120\
non-invasive ventilation , 120\
intensive inflammatory infiltrate , 120\
neutrophils , 120\
systemic methylprednisolone , 120\
topical cyclosporine , 120\
progressive resolution of mediastinitis , 168\
progressive resolution of pleural effusion , 168\
wound improvement , 168\
scar , 168\
progressive normalization of blood count , 168\
progressive normalization of flogosis index , 168\
breast ultrasound , 168\
right mastectomy , 168\
axillary dissection , 168\
breast surgical wound healing , 168\
fibroelastosis , 168\
chronic inflammation , 168\
isolated neoplastic cells , 168\
negative axillary nodes , 168\
negative restaging brain/chest/abdomen CT , 168\
negative BRCA mutation test , 168\
negative p53 mutation test , 168\
autologous skin graft , 336\
PICC implant , 336\
chemotherapy with carboplatin and paclitaxel , 336\
dose reduction , 336\
completion of chemotherapy , 504\
follow-up , 504
